Mota et al. [36] summarized that several signaling pathways including BCL2L11-mediated mitochondrial apoptosis were enhanced by lipotoxicity and glucotoxicity to accelerate hepatocellular apoptosis in NAFLD. The gene discussed is BCL2L11; the disease is metabolic dysfunction-associated steatotic liver disease.